Literature DB >> 12734687

Epidemiology of Hodgkin's disease and non-Hodgkin's lymphoma.

A J Swerdlow1.   

Abstract

This review considers in detail the descriptive and aetiological epidemiology of Hodgkin's disease and non-Hodgkin's lymphoma (NHL), with attention to histological subcategories when the literature allows. The aetiology of Hodgkin's disease remains only partially understood. There is evidence that Epstein-Barr virus (EBV) may be involved in the causation of some cases, and clinical immune deficiency is a risk factor for a few, but the evidence is not entirely consistent and other factors may also be important in causing the EBV-associated cases of Hodgkin's disease. The cause of EBV-unassociated cases remains obscure. For NHL, although it has been shown that some cases are related to immune deficiency and chronic antigenic stimulation, and especially to EBV in the context of immune deficiency, the causation of the majority of cases remains unknown. The increasing incidence of NHL, other than that related to AIDS, is also essentially unexplained. Epidemiological investigation of the aetiology of NHL and Hodgkin's disease is making steady progress, however, and there remain leads to be followed that may result in a better understanding and hence prevention.

Entities:  

Mesh:

Year:  2003        PMID: 12734687     DOI: 10.1007/s00259-003-1154-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  89 in total

Review 1.  AIDS-associated non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy.

Authors:  A E Grulich
Journal:  J Acquir Immune Defic Syndr       Date:  1999-08-01       Impact factor: 3.731

2.  Epstein-Barr virus in Hodgkin's disease: correlation of risk factors and disease characteristics with molecular evidence of viral infection.

Authors:  B G Sleckman; P M Mauch; R F Ambinder; R Mann; G S Pinkus; M E Kadin; B Sherburne; A Perez-Atayde; I Thior; N Mueller
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-12       Impact factor: 4.254

3.  Agricultural exposure to carbamate pesticides and risk of non-Hodgkin lymphoma.

Authors:  T Zheng; S H Zahm; K P Cantor; D D Weisenburger; Y Zhang; A Blair
Journal:  J Occup Environ Med       Date:  2001-07       Impact factor: 2.162

4.  Survival of childhood lymphomas in Europe, 1978--1992: a report from the EUROCARE study.

Authors:  G Pastore; C Magnani; A Verdecchia; A Pession; S Viscomi; J W Coebergh
Journal:  Eur J Cancer       Date:  2001-04       Impact factor: 9.162

5.  International patterns in the occurrence of Hodgkin's disease in children and young adult males.

Authors:  G J Macfarlane; T Evstifeeva; P Boyle; S Grufferman
Journal:  Int J Cancer       Date:  1995-04-10       Impact factor: 7.396

6.  A population-based study of cancer risk in twins: relationships to birth order and sexes of the twin pair.

Authors:  A J Swerdlow; B De Stavola; N Maconochie; V Siskind
Journal:  Int J Cancer       Date:  1996-08-07       Impact factor: 7.396

7.  Agricultural risk factors for t(14;18) subtypes of non-Hodgkin's lymphoma.

Authors:  J C Schroeder; A F Olshan; R Baric; G A Dent; C R Weinberg; B Yount; J R Cerhan; C F Lynch; L M Schuman; P E Tolbert; N Rothman; K P Cantor; A Blair
Journal:  Epidemiology       Date:  2001-11       Impact factor: 4.822

Review 8.  Reproductive factors in Hodgkin's disease in women: a review.

Authors:  S L Glaser
Journal:  Am J Epidemiol       Date:  1994-02-01       Impact factor: 4.897

9.  Effect of human T-lymphotropic virus type I infection on non-Hodgkin's lymphoma incidence.

Authors:  F R Cleghorn; A Manns; R Falk; P Hartge; B Hanchard; N Jack; E Williams; E Jaffe; F White; C Bartholomew
Journal:  J Natl Cancer Inst       Date:  1995-07-05       Impact factor: 13.506

10.  Risk of non-Hodgkin's lymphoma following tuberculosis.

Authors:  J Askling; A Ekbom
Journal:  Br J Cancer       Date:  2001-01-05       Impact factor: 7.640

View more
  15 in total

1.  Occupational exposure to high molecular weight allergens and lymphoma risk among Italian adults.

Authors:  Maria C Mirabelli; Jan-Paul Zock; Angelo D'Errico; Manolis Kogevinas; Silvia de Sanjosé; Lucia Miligi; Adele Seniori Costantini; Paolo Vineis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-09-15       Impact factor: 4.254

Review 2.  Combined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin's lymphoma: a systematic review.

Authors:  Christine Herbst; Fareed A Rehan; Corinne Brillant; Julia Bohlius; Nicole Skoetz; Holger Schulz; Ina Monsef; Lena Specht; Andreas Engert
Journal:  Haematologica       Date:  2009-11-30       Impact factor: 9.941

3.  (99m)Tc-rituximab radiolabelled by photo-activation: a new non-Hodgkin's lymphoma imaging agent.

Authors:  T Gmeiner Stopar; I Mlinaric-Rascan; J Fettich; S Hojker; S J Mather
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-09-20       Impact factor: 9.236

4.  Regarding "meta-analysis and causal inference: a case study of benzene and non-Hodgkin lymphoma": an incomplete analysis.

Authors:  Craig Steinmaus; Allan H Smith; Martyn T Smith
Journal:  Ann Epidemiol       Date:  2010-08-12       Impact factor: 3.797

Review 5.  [Radiological diagnostics of Hodgkin- and non-Hodgkin lymphomas of the thorax].

Authors:  M Uffmann; C Schaefer-Prokop
Journal:  Radiologe       Date:  2004-05       Impact factor: 0.635

6.  HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection.

Authors:  Karen A McAulay; Craig D Higgins; Karen F Macsween; Annette Lake; Ruth F Jarrett; Faye L Robertson; Hilary Williams; Dorothy H Crawford
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

7.  Paediatric and adolescent Hodgkin lymphoma: information derived from diffuse organ uptake of 18 F-fluorodeoxyglucose on pre-treatment and on interim PET/CT.

Authors:  Linda Jorgov; Françoise Montravers; Sona Balogova; Christine Ragu; Hélène Pacquement; Thierry Leblanc; Samuel Abbou; Hubert Ducou-Lepointe; Judith Landman-Parker; Jean-Noёl Talbot
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-12-14       Impact factor: 9.236

8.  The predictive significance of CD20 expression in B-cell lymphomas.

Authors:  Veronika Kloboves Prevodnik; Jaka Lavrenčak; Mateja Horvat; Barbara Jezeršek Novakovič
Journal:  Diagn Pathol       Date:  2011-04-12       Impact factor: 2.644

9.  Gender and ploidy in cancer survival.

Authors:  Susanne Schulze; Iver Petersen
Journal:  Cell Oncol (Dordr)       Date:  2011-03-22       Impact factor: 6.730

10.  Antibiotic use and risk of non-Hodgkin's lymphoma: a population-based case-control study.

Authors:  L A Anderson; G Gridley; E A Engels; L M Morton; J R Cerhan; W Cozen; R K Severson; S Davis; P Hartge; M S Linet
Journal:  Br J Cancer       Date:  2007-12-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.